keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Enloplatin is a carboplatin analog that has a partial role in advanced ovarian cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 76.00 | |
5 mg | In stock | $ 177.00 | |
10 mg | In stock | $ 260.00 | |
25 mg | In stock | $ 506.00 | |
50 mg | In stock | $ 690.00 | |
100 mg | In stock | $ 982.00 | |
500 mg | In stock | $ 1,970.00 |
Description | Enloplatin is a carboplatin analog that has a partial role in advanced ovarian cancer. |
Targets&IC50 | Tera (cells):7.2 µM |
In vivo | Enloplatin (i.v. infusion; over 1.5 h; every 21 days), one patient had a partial response (6%; 95% CI 0-26%) lasting 2.8 months. The median survival was 9.4 months (95%; CI 5.1-19.7%). Neutropenia was the dose-limiting toxicity. Nephrotoxicity was manageable. Enloplatin is the major form of the free drug in plasma. However, 13.5 h after initiation of treatment, 85% of the drug in plasma is protein bound. Elimination of the drug is mainly renal.[1] |
Molecular Weight | 481.4 |
Formula | C13H22N2O5Pt |
CAS No. | 111523-41-2 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (114.25 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Enloplatin 111523-41-2 inhibitor inhibit